Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-12

Clinical Trial Update: Comparison of Topical Silymarin With Hydroquinone in the Treatment of Melasma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing topical silymarin with hydroquinone for treatment of melasma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydroquinone (hydroquinone)
  • Topical silymarin (silymarin)

Snippet

Sponsor: Islamabad Medical and Dental College | Conditions: Melasma | Phase 2 | Status: COMPLETED